vs
Side-by-side financial comparison of HALOZYME THERAPEUTICS, INC. (HALO) and Westrock Coffee Co (WEST). Click either name above to swap in a different company.
HALOZYME THERAPEUTICS, INC. is the larger business by last-quarter revenue ($451.8M vs $339.5M, roughly 1.3× Westrock Coffee Co). Westrock Coffee Co runs the higher net margin — -6.6% vs -31.3%, a 24.7% gap on every dollar of revenue. On growth, HALOZYME THERAPEUTICS, INC. posted the faster year-over-year revenue change (51.6% vs 48.3%). HALOZYME THERAPEUTICS, INC. produced more free cash flow last quarter ($217.6M vs $27.8M). Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs 32.8%).
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
Westrock Coffee Co is a global integrated coffee, tea and functional beverage solutions provider. It sources, roasts, manufactures and distributes coffee products, ready-to-drink beverages and custom formulations for retail, foodservice and commercial clients across North America and other key markets.
HALO vs WEST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $451.8M | $339.5M |
| Net Profit | $-141.6M | $-22.6M |
| Gross Margin | 82.6% | 11.5% |
| Operating Margin | -20.6% | -2.6% |
| Net Margin | -31.3% | -6.6% |
| Revenue YoY | 51.6% | 48.3% |
| Net Profit YoY | -203.3% | 8.3% |
| EPS (diluted) | $-1.13 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $451.8M | $339.5M | ||
| Q3 25 | $354.3M | $354.8M | ||
| Q2 25 | $325.7M | $280.9M | ||
| Q1 25 | $264.9M | $213.8M | ||
| Q4 24 | $298.0M | $229.0M | ||
| Q3 24 | $290.1M | $220.9M | ||
| Q2 24 | $231.4M | $208.4M | ||
| Q1 24 | $195.9M | $192.5M |
| Q4 25 | $-141.6M | $-22.6M | ||
| Q3 25 | $175.2M | $-19.1M | ||
| Q2 25 | $165.2M | $-21.6M | ||
| Q1 25 | $118.1M | $-27.2M | ||
| Q4 24 | $137.0M | $-24.6M | ||
| Q3 24 | $137.0M | $-14.3M | ||
| Q2 24 | $93.2M | $-17.8M | ||
| Q1 24 | $76.8M | $-23.7M |
| Q4 25 | 82.6% | 11.5% | ||
| Q3 25 | 84.4% | 11.7% | ||
| Q2 25 | 85.8% | 14.7% | ||
| Q1 25 | 81.7% | 13.6% | ||
| Q4 24 | 85.9% | 16.6% | ||
| Q3 24 | 83.0% | 16.8% | ||
| Q2 24 | 82.9% | 19.9% | ||
| Q1 24 | 85.5% | 19.4% |
| Q4 25 | -20.6% | -2.6% | ||
| Q3 25 | 61.5% | -2.4% | ||
| Q2 25 | 62.2% | -5.3% | ||
| Q1 25 | 53.4% | -6.1% | ||
| Q4 24 | 58.9% | -4.3% | ||
| Q3 24 | 56.3% | -5.8% | ||
| Q2 24 | 50.7% | -7.9% | ||
| Q1 24 | 48.8% | -5.3% |
| Q4 25 | -31.3% | -6.6% | ||
| Q3 25 | 49.5% | -5.4% | ||
| Q2 25 | 50.7% | -7.7% | ||
| Q1 25 | 44.6% | -12.7% | ||
| Q4 24 | 46.0% | -10.7% | ||
| Q3 24 | 47.2% | -6.5% | ||
| Q2 24 | 40.3% | -8.5% | ||
| Q1 24 | 39.2% | -12.3% |
| Q4 25 | $-1.13 | $-0.22 | ||
| Q3 25 | $1.43 | $-0.20 | ||
| Q2 25 | $1.33 | $-0.23 | ||
| Q1 25 | $0.93 | $-0.29 | ||
| Q4 24 | $1.06 | $-0.26 | ||
| Q3 24 | $1.05 | $-0.16 | ||
| Q2 24 | $0.72 | $-0.20 | ||
| Q1 24 | $0.60 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.8M | $49.9M |
| Total DebtLower is stronger | $2.1B | $444.1M |
| Stockholders' EquityBook value | $48.8M | $-1.9M |
| Total Assets | $2.5B | $1.2B |
| Debt / EquityLower = less leverage | 43.89× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.8M | $49.9M | ||
| Q3 25 | $419.7M | $34.0M | ||
| Q2 25 | $61.9M | $44.0M | ||
| Q1 25 | $176.3M | $33.1M | ||
| Q4 24 | $115.8M | $26.2M | ||
| Q3 24 | $154.3M | $22.4M | ||
| Q2 24 | $187.9M | $24.3M | ||
| Q1 24 | $164.6M | $12.6M |
| Q4 25 | $2.1B | $444.1M | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | $393.1M | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $48.8M | $-1.9M | ||
| Q3 25 | $503.9M | $11.4M | ||
| Q2 25 | $332.7M | $18.2M | ||
| Q1 25 | $482.3M | $71.4M | ||
| Q4 24 | $363.8M | $97.5M | ||
| Q3 24 | $452.7M | $110.3M | ||
| Q2 24 | $289.4M | $81.5M | ||
| Q1 24 | $177.8M | $91.7M |
| Q4 25 | $2.5B | $1.2B | ||
| Q3 25 | $2.2B | $1.2B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $2.2B | $1.1B | ||
| Q4 24 | $2.1B | $1.1B | ||
| Q3 24 | $2.1B | $1.1B | ||
| Q2 24 | $2.0B | $1.1B | ||
| Q1 24 | $1.8B | $983.3M |
| Q4 25 | 43.89× | — | ||
| Q3 25 | 3.00× | — | ||
| Q2 25 | 4.54× | — | ||
| Q1 25 | 3.13× | — | ||
| Q4 24 | 4.14× | 4.03× | ||
| Q3 24 | 3.32× | — | ||
| Q2 24 | 5.19× | — | ||
| Q1 24 | 8.44× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $219.0M | $36.7M |
| Free Cash FlowOCF − Capex | $217.6M | $27.8M |
| FCF MarginFCF / Revenue | 48.2% | 8.2% |
| Capex IntensityCapex / Revenue | 0.3% | 2.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $644.6M | $-107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $219.0M | $36.7M | ||
| Q3 25 | $178.6M | $-26.6M | ||
| Q2 25 | $99.7M | $-7.0M | ||
| Q1 25 | $154.2M | $-22.1M | ||
| Q4 24 | $178.5M | $2.8M | ||
| Q3 24 | $115.4M | $-332.0K | ||
| Q2 24 | $55.8M | $-23.7M | ||
| Q1 24 | $129.4M | $8.0M |
| Q4 25 | $217.6M | $27.8M | ||
| Q3 25 | $175.6M | $-44.7M | ||
| Q2 25 | $98.1M | $-27.5M | ||
| Q1 25 | $153.3M | $-63.4M | ||
| Q4 24 | $175.4M | $-15.4M | ||
| Q3 24 | $113.9M | $-36.7M | ||
| Q2 24 | $53.2M | $-59.9M | ||
| Q1 24 | $125.9M | $-60.9M |
| Q4 25 | 48.2% | 8.2% | ||
| Q3 25 | 49.6% | -12.6% | ||
| Q2 25 | 30.1% | -9.8% | ||
| Q1 25 | 57.9% | -29.7% | ||
| Q4 24 | 58.9% | -6.7% | ||
| Q3 24 | 39.3% | -16.6% | ||
| Q2 24 | 23.0% | -28.7% | ||
| Q1 24 | 64.3% | -31.7% |
| Q4 25 | 0.3% | 2.6% | ||
| Q3 25 | 0.9% | 5.1% | ||
| Q2 25 | 0.5% | 7.3% | ||
| Q1 25 | 0.4% | 19.3% | ||
| Q4 24 | 1.0% | 7.9% | ||
| Q3 24 | 0.5% | 16.5% | ||
| Q2 24 | 1.1% | 17.4% | ||
| Q1 24 | 1.8% | 35.8% |
| Q4 25 | — | — | ||
| Q3 25 | 1.02× | — | ||
| Q2 25 | 0.60× | — | ||
| Q1 25 | 1.31× | — | ||
| Q4 24 | 1.30× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.60× | — | ||
| Q1 24 | 1.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
